https://the483.com/moonshot-kimi-k3-anthropic-distillation/ The 483 en 2026-07-22T21:37:30.000Z Moonshot's Kimi K3: 3.4M Claude Queries, No License https://the483.com/nih-genesis-mission-ai-funding/ The 483 en 2026-07-22T21:07:47.000Z NIH Taps $1.2B AI Fund in Trump's Genesis Mission https://the483.com/doj-crypto-forfeiture-scam-networks/ The 483 en 2026-07-22T20:45:40.000Z DOJ Sues to Seize $25M in Scam Crypto https://the483.com/gsk-jideytro-fda-approval-nuvalent/ The 483 en 2026-07-22T20:34:17.567Z GSK's Jideytro Wins First FDA Lung Cancer Nod https://the483.com/ashlins-lees-pharm-interferon-license/ The 483 en 2026-07-22T11:34:37.000Z Licenses $31M Interferon Drug, Ashlins Preps $50M Raise https://the483.com/crl-nclc-colorado-section-525/ The 483 en 2026-07-22T10:55:13.000Z Filed: CRL, NCLC Back Colorado on Section 525 https://the483.com/astrazeneca-wainua-flop-80b-goal/ The 483 en 2026-07-22T10:03:47.000Z Cuts $1.9B from AstraZeneca's $80B goal after Wainua flop https://the483.com/fed-bars-james-burns-heritage-bank/ The 483 en 2026-07-21T22:06:50.000Z Barred Ex-Heritage Bank Chief Burns Over Inflated Loans https://the483.com/agios-tebapivat-sickle-cell-novo-etavopivat/ The 483 en 2026-07-21T21:37:54.000Z Agios Kills Tebapivat, Novo's Etavopivat Wins https://the483.com/bell-policy-center-colorado-rate-cap/ The 483 en 2026-07-21T21:07:55.000Z Bell Policy Center Defends Colorado's 36% Rate Cap https://the483.com/paramount-warner-bros-deal-frozen/ The 483 en 2026-07-21T20:39:39.000Z Freezes Paramount's $110B Warner Bros Buy https://the483.com/alvelais-sentenced-scoular-fcpa/ The 483 en 2026-07-21T20:35:26.369Z Sentenced: Alvelais Gets 18 Months, Scoular Pays $10M https://the483.com/chris-fall-resigns-caisi/ The 483 en 2026-07-21T10:05:07.000Z Chris Fall Quits CAISI After 3 Months on Job https://the483.com/coupang-422-million-fine-korea/ The 483 en 2026-07-21T09:15:52.185Z Fined $422M, Coupang Sparks US-Korea Clash https://the483.com/samsung-biologics-buys-polypeptide/ The 483 en 2026-07-20T21:50:55.000Z Bought PolyPeptide for $1.8B in Samsung's Peptide Push